Health
Hard choices emerge as link between AstraZeneca vaccine and rare clotting disorder becomes clearer – Science Magazine
Some scientists suggest halving the dose might reduce risks and help protect more people from COVID-19
By Kai Kupferschmidt, Gretchen VogelApr. 11, 2021 , 7:15 AM
Sciences COVID-19 reporting is supported by the Heising-Simons Foundation.
What was a worrisome suspicion four weeks ago is now widely accepted: The AstraZeneca COVID-19 vaccine can, in very rare cases, cause a disorder characterized by dangerous blood clots and low platelet counts. In Europe, at least 222 suspected cases have been reported among 34 million who have received their first dose of the vaccine. More than 30 have died.
Causality…
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General13 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News22 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General13 hours agoOf saints and sinners | The Spectator Australia